31
Participants
Start Date
April 30, 2008
Primary Completion Date
August 31, 2012
Study Completion Date
July 31, 2014
Leptin
Leptin self-administered subcutaneously at 0.05 mg/kg body weight twice each day
Placebo
Sterile water equal in volume to that of the metreleptin dose calculated for each individual self-administered subcutaneously twice each day
Columbia University Medical Center, New York
Collaborators (1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Amylin Pharmaceuticals, LLC.
INDUSTRY
National Center for Research Resources (NCRR)
NIH
Columbia University
OTHER